Aspire BioPharma is trading at $6.85 (down 5.5%) as the stock retraces gains from an earlier sector-wide biotech rally.
- The move follows a strong regular-session performance, with no new company-specific news or earnings reports released after the close.
- Price action appears driven by thin after-hours liquidity, which often leads to larger swings on lower trading volume.